Unsaturated Fatty Alcohol Derivatives of Olive Oil Phenolic Compounds with Potential Low-Density Lipoprotein (LDL) Antioxidant and Antiobesity Properties

A new route for the synthesis of fatty alcohol derivatives of hydroxytyrosol and other olive oil phenolic compounds was developed to allow the preparation of unsaturated derivatives. The biological activity of synthesized compounds was evaluated. Most of the compounds presented a significant antioxi...

Full description

Saved in:
Bibliographic Details
Published inJournal of agricultural and food chemistry Vol. 60; no. 4; pp. 1067 - 1074
Main Authors Cotrim, Bruno Almeida, Joglar, Jesús, Rojas, M. Jesús L, del Olmo, Juan Manuel Decara, Macias-González, Manuel, Cuevas, Miguel Romero, Fitó, Montserrat, Muñoz-Aguayo, Daniel, Covas Planells, María Isabel, Farré, Magí, Rodríguez de Fonseca, Fernando, de la Torre, Rafael
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.02.2012
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new route for the synthesis of fatty alcohol derivatives of hydroxytyrosol and other olive oil phenolic compounds was developed to allow the preparation of unsaturated derivatives. The biological activity of synthesized compounds was evaluated. Most of the compounds presented a significant antioxidant activity on low-density lipoprotein (LDL) particles. The activity of the tested products was significantly influenced by the number and position of unsaturations as well as modifications on the polar head of the synthesized compounds. Some of them presented modulation of food intake in rats and, due to their molecular similarity with CB1 endogenous ligands, the endocannabinoid system and PPAR-α were also evaluated as potential targets. The pharmacodynamics could not be totally explained by CB1 and PPAR-α receptor interactions because only two of the four compounds with biological activity showed a CB1 activity and all of them presented low PPAR-α affinity, not justifying its whole in vivo activity. The hydroxytyrosol linoleylether (7) increased LDL resistance to oxidation with a capacity similar to that of hydroxytyrosol and was the most active in vivo compound with a hypophagic effect comparable to that of oleoylethanolamine. We consider that this compound could be a good lead compound for future drug development in obesity treatments.
Bibliography:http://dx.doi.org/10.1021/jf203814r
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-8561
1520-5118
DOI:10.1021/jf203814r